703 related articles for article (PubMed ID: 18789586)
1. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of amikacin in the subeschar tissue fluid following severe burns].
Yang RH; Rong XZ; Zhang T; Hua R
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):172-4. PubMed ID: 17355928
[TBL] [Abstract][Full Text] [Related]
3. [Changes in pharmacokinetic parameters of vancomycin in the subeschar tissue fluid in patients with severe burns].
Yang RH; Rong XZ; Zhang T; Hua R
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):94-6. PubMed ID: 17649880
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics changes of amikacin in severe burn patients at early stage].
Hua R; Rong XZ; Zhang T; Yang RH
Zhonghua Shao Shang Za Zhi; 2008 Feb; 24(1):33-5. PubMed ID: 18512557
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of the postburn retention and the metabolism of Imipenem in the third space].
Rong XZ; Bei CH; Huang XH; Li QH
Zhonghua Shao Shang Za Zhi; 2003 Apr; 19(2):75-7. PubMed ID: 12812629
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic changes of blister fluid amikacin concentration after its early-stage administration in severely burned patients].
Hua R; Rong XZ; Zhang T; Yang RH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1522-3. PubMed ID: 17959530
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics differences of propofol during different pathological stages of severe burn in rabbits].
Hu QG; Hao JH; Chai JK; Yang HM; Sun XF; Li P; Li MM; Liu S
Zhonghua Shao Shang Za Zhi; 2010 Feb; 26(1):37-40. PubMed ID: 20510032
[TBL] [Abstract][Full Text] [Related]
9. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.
Conil JM; Georges B; Breden A; Segonds C; Lavit M; Seguin T; Coley N; Samii K; Chabanon G; Houin G; Saivin S
Int J Antimicrob Agents; 2006 Sep; 28(3):226-30. PubMed ID: 16908121
[TBL] [Abstract][Full Text] [Related]
10. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
Taccone FS; de Backer D; Laterre PF; Spapen H; Dugernier T; Delattre I; Wallemacq P; Vincent JL; Jacobs F
Int J Antimicrob Agents; 2011 Jun; 37(6):531-5. PubMed ID: 21489756
[TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.
KuKanich B; Coetzee JF
J Vet Pharmacol Ther; 2008 Apr; 31(2):102-7. PubMed ID: 18307501
[TBL] [Abstract][Full Text] [Related]
14. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
15. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
[TBL] [Abstract][Full Text] [Related]
17. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
[TBL] [Abstract][Full Text] [Related]
18. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
[TBL] [Abstract][Full Text] [Related]
19. [Changes in proinflammatory cytokines and immune function of subeschar tissue fluid during early stage after severe burn].
Rong XZ; Li QH; Huang XH; Bei CH; Liu ZQ; Su YM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):612-4. PubMed ID: 14552686
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
